Literature DB >> 18827133

Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics.

Karen Hoover1, Guoyu Tao, Charlotte Kent.   

Abstract

OBJECTIVE: To estimate demographic characteristics of nonpregnant women who seek health care in hospital outpatient clinics, and the proportion of visits where a chlamydia test was not done in asymptomatic young women at preventive visits and in symptomatic women.
METHODS: We analyzed data from the 2005 National Hospital Ambulatory Medical Care Survey to estimate the number of visits made by nonpregnant women aged 15-25 years and 26-35 years. We estimated the proportion of preventive visits where young women were not screened for chlamydia and the proportion of visits where women with signs or symptoms of chlamydia were not tested.
RESULTS: In 2005, 5.2 million visits were made by nonpregnant women aged 15-25 years to outpatient clinics: 21.3% were by black non-Hispanic women, 15.2% by Hispanic women, 41.9% by women with Medicaid/State Children's Health Insurance Program insurance, and 10.8% by women with signs or symptoms of chlamydia. These young women were not screened at 84.0% of 1.2 million asymptomatic preventive visits, and were not tested for chlamydia at 78.3% of 0.6 million visits where they presented with signs or symptoms of chlamydia. Women aged 26-35 years were not tested at 86.3% of 0.4 million visits where they presented with signs or symptoms of chlamydia.
CONCLUSION: While low chlamydia screening coverage has been reported, the low level of diagnostic testing in outpatient clinics was unexpected. Simple and effective interventions are needed to increase both diagnostic testing and screening of young women for Chlamydia in outpatient clinics, a venue that provides care to at-risk populations.

Entities:  

Mesh:

Year:  2008        PMID: 18827133     DOI: 10.1097/AOG.0b013e318185a057

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Comparison of adherence to chlamydia screening guidelines among Title X providers and non-Title X providers in the California Family Planning, Access, Care, and Treatment Program.

Authors:  Joan M Chow; Heike Thiel de Bocanegra; Denis Hulett; Hye-Youn Park; Philip Darney
Journal:  J Womens Health (Larchmt)       Date:  2012-06-13       Impact factor: 2.681

2.  Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.

Authors:  Jennifer E Balkus; Lisa E Manhart; Jeannette Lee; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

Review 3.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

4.  Chlamydia screening among young women: individual- and provider-level differences in testing.

Authors:  Sarah E Wiehe; Marc B Rosenman; Jane Wang; Barry P Katz; J Dennis Fortenberry
Journal:  Pediatrics       Date:  2011-01-24       Impact factor: 7.124

5.  The Proportion of Young Women Tested for Chlamydia Who Had Urogenital Symptoms in Physician Offices.

Authors:  Chirag G Patel; Shivika Trivedi; Guoyu Tao
Journal:  Sex Transm Dis       Date:  2018-09       Impact factor: 2.830

6.  Higher yet suboptimal chlamydia testing rates at community health centers and outpatient clinics compared with physician offices.

Authors:  Jeffrey M Eugene; Karen W Hoover; Guoyu Tao; Charlotte K Kent
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

7.  Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S.

Authors:  Kwame Owusu-Edusei; Karen W Hoover; Thomas L Gift
Journal:  Am J Prev Med       Date:  2016-03-04       Impact factor: 5.043

8.  Sexually transmitted infection prevalence in a population seeking no-cost contraception.

Authors:  Colleen McNicholas; Jeffrey F Peipert; Ragini Maddipati; Tessa Madden; Jenifer E Allsworth; Gina M Secura
Journal:  Sex Transm Dis       Date:  2013-07       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.